Alzheimer's Disease

Prana Alzheimer’s disease Development Plan Update

Prana Biotechnology (ASX:PBT) has today provided an update on its clinical development program for Alzheimer’s disease.


Movement disorders expert Professor Ira Shoulson joins Prana Biotechnology's Board of Directors

Email Newsletter

Receive regular updates from Prana Biotechnology by entering your details below and clicking "Subscribe"